ClinicalThought

Share

Program Content

Activities

  • Immune Checkpoint Inhibitors
    Immune Checkpoint Inhibitors: A New Hope for Patients With Merkel Cell Carcinoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 30, 2016

    Expires: November 29, 2017

  • Metastatic MCC Immunotherapy
    Rapid Response in a Patient With Bulky Liver Metastases From Merkel Cell Carcinoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 27, 2017

    Expires: February 26, 2018

  • Avelumab for MCC
    Avelumab: A New Treatment Paradigm for Metastatic Merkel Cell Carcinoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 19, 2017

    Expires: May 18, 2018

  • MCC: T-Cell Therapy
    T-Cell Therapy Plus Avelumab: A New Approach in Merkel Cell Carcinoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2017

    Expires: August 08, 2018

Faculty

cover img faculity

Shailender Bhatia, MD

Associate Professor
Division of Medical Oncology
Department of Medicine
University of Washington
Attending Physician
Seattle Cancer Care Alliance
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

Howard L. Kaufman, MD

Associate Director for Clinical Sciences
Chief Surgical Officer

Department of Surgical Oncology
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

cover img faculity

Paul Nghiem, MD

Professor and Head
Division of Dermatology
Department of Medicine
University of Washington
Seattle, Washington

Provided by

ProCE Banner

Supporters

Merck KGaA

Pfizer, Inc.